These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34076593)
1. FragMAXapp: crystallographic fragment-screening data-analysis and project-management system. Lima GMA; Jagudin E; Talibov VO; Benz LS; Marullo C; Barthel T; Wollenhaupt J; Weiss MS; Mueller U Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):799-808. PubMed ID: 34076593 [TBL] [Abstract][Full Text] [Related]
2. FragMAX: the fragment-screening platform at the MAX IV Laboratory. Lima GMA; Talibov VO; Jagudin E; Sele C; Nyblom M; Knecht W; Logan DT; Sjögren T; Mueller U Acta Crystallogr D Struct Biol; 2020 Aug; 76(Pt 8):771-777. PubMed ID: 32744259 [TBL] [Abstract][Full Text] [Related]
4. Fast fragment- and compound-screening pipeline at the Swiss Light Source. Kaminski JW; Vera L; Stegmann DP; Vering J; Eris D; Smith KML; Huang CY; Meier N; Steuber J; Wang M; Fritz G; Wojdyla JA; Sharpe ME Acta Crystallogr D Struct Biol; 2022 Mar; 78(Pt 3):328-336. PubMed ID: 35234147 [TBL] [Abstract][Full Text] [Related]
10. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery. Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045 [TBL] [Abstract][Full Text] [Related]
11. Accurate macromolecular crystallographic refinement: incorporation of the linear scaling, semiempirical quantum-mechanics program DivCon into the PHENIX refinement package. Borbulevych OY; Plumley JA; Martin RI; Merz KM; Westerhoff LM Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1233-47. PubMed ID: 24816093 [TBL] [Abstract][Full Text] [Related]
12. Crystallographic fragment screening in academic cancer drug discovery. Martin MP; Endicott JA; Noble MEM; Tatum NJ Methods Enzymol; 2023; 690():211-234. PubMed ID: 37858530 [TBL] [Abstract][Full Text] [Related]
13. Fast fragment and compound screening pipeline at the Swiss Light Source. Stegmann DP; Steuber J; Fritz G; Wojdyla JA; Sharpe ME Methods Enzymol; 2023; 690():235-284. PubMed ID: 37858531 [TBL] [Abstract][Full Text] [Related]
14. High-throughput quantum-mechanics/molecular-mechanics (ONIOM) macromolecular crystallographic refinement with PHENIX/DivCon: the impact of mixed Hamiltonian methods on ligand and protein structure. Borbulevych O; Martin RI; Westerhoff LM Acta Crystallogr D Struct Biol; 2018 Nov; 74(Pt 11):1063-1077. PubMed ID: 30387765 [TBL] [Abstract][Full Text] [Related]
15. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking. Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087 [TBL] [Abstract][Full Text] [Related]
16. Application of in situ diffraction in high-throughput structure determination platforms. Aller P; Sanchez-Weatherby J; Foadi J; Winter G; Lobley CM; Axford D; Ashton AW; Bellini D; Brandao-Neto J; Culurgioni S; Douangamath A; Duman R; Evans G; Fisher S; Flaig R; Hall DR; Lukacik P; Mazzorana M; McAuley KE; Mykhaylyk V; Owen RL; Paterson NG; Romano P; Sandy J; Sorensen T; von Delft F; Wagner A; Warren A; Williams M; Stuart DI; Walsh MA Methods Mol Biol; 2015; 1261():233-53. PubMed ID: 25502203 [TBL] [Abstract][Full Text] [Related]
17. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology. Böttcher J; Jestel A; Kiefersauer R; Krapp S; Nagel S; Steinbacher S; Steuber H Methods Enzymol; 2011; 493():61-89. PubMed ID: 21371587 [TBL] [Abstract][Full Text] [Related]
18. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. McPhillips TM; McPhillips SE; Chiu HJ; Cohen AE; Deacon AM; Ellis PJ; Garman E; Gonzalez A; Sauter NK; Phizackerley RP; Soltis SM; Kuhn P J Synchrotron Radiat; 2002 Nov; 9(Pt 6):401-6. PubMed ID: 12409628 [TBL] [Abstract][Full Text] [Related]
19. Crystallographic analysis of TPP riboswitch binding by small-molecule ligands discovered through fragment-based drug discovery approaches. Warner KD; Ferré-D'Amaré AR Methods Enzymol; 2014; 549():221-33. PubMed ID: 25432751 [TBL] [Abstract][Full Text] [Related]
20. MS methods to study macromolecule-ligand interaction: Applications in drug discovery. Riccardi Sirtori F; Altomare A; Carini M; Aldini G; Regazzoni L Methods; 2018 Jul; 144():152-174. PubMed ID: 29890284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]